Incurable esophageal cancer: Patterns of tumor spread and therapeutic consequences

World Journal of Surgery

Volumn 30, Issue 2, 2006, Pages 183-190

  Gockel, Ines ^a   Kneist, Werner ^a   Junginger, Theodor ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GENERAL CONDITION; HISTOLOGY; HUMAN; INOPERABLE CANCER; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TIME SERIES ANALYSIS; TREATMENT CONTRAINDICATION; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLIATIVE CARE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TERMINALLY ILL;

EID: 31544463298     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-7861-6     Document Type: Article

References (30)

1. Bollschweiler E, Schroder W, Holscher AH, et al. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the esophagus. Br J Surg 2000;87:1106-1110.
2. Siewert JR, Stein HJ, Sendler A. Esophageal cancer: clinical management. In Kelsen DA, ed., Principles and Practice of Gastrointestinal Oncology, Philadelphia, Lippincott Williams & Wilkins, 2001.
3. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360-369.
4. Holscher AH, Bollschweiler E, Schneider PM, et al. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 1995;76:178-186.
5. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric junction. JAMA 1991;265:1287-1289.
6. Fu JH, Rong TH, Li XD, et al. Cox regression analysis of the prognostic factors of unresectable esophageal carcinoma after stenting. Ai Zheng 2003;22:91-94.
7. Hagen JA, Peters JH, DeMeester TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993;106:850-858.
8. Kneist W, Schreckenberger M, Bartenstein P, et al. Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg 2004;139:1043-1049.
9. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;11:326:1593-1598.
10. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-513.
11. Wang HH, Antonioli DA, Goldman H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol 1986;17:482-487.
12. Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histologic type. Cancer 1988;61:612-617.
13. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303-321.
14. Tachimori Y, Kato H, Watanabe H, et al. Difference between carcinoma of the lower esophagus and the cardia. World J Surg 1996;20:507-511.
15. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23.
16. Fritz P, Stoll P, Wannenmacher M, et al. Primäre Radiochemotherapie inoperabler fortgeschrittener Ösophaguskarzinome. Strahlenther Onkol 2003;179:328-336.
17. Roussel A, Haegele P, Paillot B, et al. Results of the EORTC-GTCCG Phase III trial of irradiation versus irradiation and CDDP in inoperable esophageal cancer. For the Gastrointestinal Tract Cancer Cooperative Group. Proc Am Soc Clin Oncol 1994;13:583.
18. Lu XJ, Miao RH, Li XQ. Combination of selective arterial infusion chemotherapy with radiotherapy in the treatment of advanced esophageal carcinoma. Chin J Clin Oncol 1995;22:262-265.
19. Kaneta R, Takai Y, Nomoto K, et al. Effect of combination chemotherapy with daily low-dose CDDP for esophageal cancer: results of a randomized trial. Jpn J Cancer Chemother 1997;24:2099-2104.
20. Slabber CR, Nel JS, Schoeman L, et al. A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 1998;21:462-465.
21. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999;281:1623-1627.
22. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review). Oxford: The Cochrane Library, Issue 4 (actualized software).
23. Urba SG, Chansky K, van Veldhuizen PJ, et al. Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group study. Investigational New Drugs 2004;22:91-97.
24. Bleiberg H, Conroy T, Paillot B, et al. Randomized phase II study of cisplatin and 5-fluorouracil versus cisplatin alone in advanced squamous cell carcinoma. Eur J Cancer 1997;33:1216-1220.
25. Conroy T, Etienne PL, Adenis A, et al. European Organisation for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. Ann Oncol 2002;13:721-729.
26. Webb A, Cunningham D, Scarffe JH. Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophagogastric cancer. Br J Cancer 1996;73:1260-1264.
27. Szentpali K, Palotas A, Lazar G, et al. Endoscopic intubation with conventional plastic stents: a safe and cost-effective palliation for inoperable esophageal cancer. Dysphagia 2004;19:22-27.
28. May A, Selmaier M, Hochberger J, et al. Memory metal stents for palliation of malignant obstruction of the esophagus and cardia. Gut 1995;37:309-313.
29. Dormann AJ, Eisendrath P, Wigginghaus B, et al. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy 2003;35:207-211.
30. Dallal HJ, Smith GD, Grieve DC, et al. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endsoc 2001;54:549-557.